888-776-0942 from 8 AM - 10 PM ET
Stand-alone Blood Pump Business Model is expected to Enable Expanded Use and Increased Adoption of CytoSorb®
PRINCETON, N.J. , June 1, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threa
by Nuvectra Medical | Jun 10, 2022 | Sponsored Content | 0 |
VitalFlow Prostate Reviews – Vital Flow is an all-natural dietary supplement by Sam Morgan that is designed to help men’s prostate health that has no artificial ingredients. Check its ingredients &
The following navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move through main tier links and expand / close menus in sub tiers. Up and Down arrows will open main tier menus and toggle through sub tier links. Enter and space open menus and escape cl
Please stand by, while we are checking your browser...
Please enable Cookies and reload the page.
Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.
If you are on a personal connection, like at home, you can run an anti-virus sca
Hi, what are you looking for?
According to our latest study on Hypodermic Needles Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, End User, and Usage, the market is projected to reach US$ 5,529.28 million by 2028 from US$ 3,519.53 million in 20
There were 685 press releases posted in the last 24 hours and 192,478 in the last 365 days.
DBMR analyses that the Syringes Market to be grow at a CAGR of 9.25% and is likely to reach the USD 27.98 billion by in the forecast period of 2022-2029.
Sopan Gedam
June 7, 2022 -- In the ongoing effort to improve work-life balance, a new program has launched in Britain that aims to answer the question “Can you work just four days a week and still be as productive as you were working five?”
Some 3,300 workers in 70 U.K. companies – in industri
May 24, 2022 05:58 ET | Source: Research and Markets Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Insu
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued sup
Dr Hiddo J.L. Heerspink
The twincretin tirzepatide might become part of the arsenal against diabetic kidney disease, new research suggests. Notably, the drug significantly reduced the likelihood of macroalbuminuria in a prespecified subanalysis of the SURPASS-4 clinical trial.